UPDATE: Goldman Sachs Downgrades Intra-Cellular Therapies (ITCI) to Neutral
Tweet Send to a Friend
(Updated - August 22, 2022 5:24 AM EDT)
Goldman Sachs analyst Corinne Jenkins downgraded Intra-Cellular Therapies (NASDAQ: ITCI) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Corinne Jenkins downgraded Intra-Cellular Therapies (NASDAQ: ITCI) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
